The Requirement for EFOG-M Has Not Been Established

The Army does not have an agreed-upon requirement for the EFOG-M. 215) that would (1) require the Secretary of the Army to certify by December 1, 1995, that a requirement exists for the EFOG-M and whether there is a cost-effectiveness analysis supporting such requirement and (2) limit the expenditure of funds for the EFOG-M program to that identified in the current program plan only ($280 million, based on fiscal year 1995 constant dollars) and deny continuation of the program beyond fiscal year 1998 if contract obligations are not met. The Army’s EFOG-M Advanced Technology Demonstration Plan establishes exit criteria for evaluating EFOG-M performance (see app. Resources for Fielding System Beyond the ACTD Are Not Ensured

Because of the early stage of the ACTD program, the Army has not yet planned for the personnel and funds to support, operate, and maintain the EFOG-M beyond the ACTD program. 2. 3. 4. 5. 6. Our review was not designed to evaluate the ACTD process, but rather to examine selected aspects of the acquisition of the Army’s EFOG-M system.
Why GAO Did This Study

GAO reviewed the Army's plans for acquiring the Enhanced Fiber Optic Guided Missile (EFOG-M) system.

What GAO Found

GAO found that: (1) the Army lacks a formal requirement for EFOG-M and has not prepared comprehensive comparative cost studies because requirements documents and analyses are not normally required for Advanced Concept Technology Demonstration (ACTD) programs; (2) the Army should develop the requirement documents because of its prior difficulty in justifying the systems; (3) Congress has required the Army to certify that the requirement and analyses exist by December 1, 1995; (4) the Army has not fully defined EFOG-M performance criteria to evaluate the system's military value; (5) the ACTD program may not shorten the EFOG-M acquisition process unless innovative strategies are devised and formal testing agreements are reached; and (6) resources are not available to support limited fielding of EFOG-M after the 2-year ACTD evaluation period.